| Q35235639 | A detrimental role for invariant natural killer T cells in the pathogenesis of experimental dengue virus infection |
| Q35015787 | A mycolic acid-specific CD1-restricted T cell population contributes to acute and memory immune responses in human tuberculosis infection |
| Q34172161 | Alpha-galactosylceramide as a therapeutic agent for pulmonary Mycobacterium tuberculosis infection |
| Q37499317 | Antigen Presentation by CD1 Lipids, T Cells, and NKT Cells in Microbial Immunity |
| Q33506611 | Bacillus anthracis lethal toxin disrupts TCR signaling in CD1d-restricted NKT cells leading to functional anergy |
| Q37402372 | CD1-restricted adaptive immune responses to Mycobacteria in human group 1 CD1 transgenic mice |
| Q37826931 | Cellular response to mycobacteria: balancing protection and pathology |
| Q50861399 | CpG oligonucleotide-mediated co-stimulation of mouse invariant natural killer T cells negatively regulates their activation status. |
| Q35595346 | Development of genetically engineered iNKT cells expressing TCRs specific for the M. tuberculosis 38-kDa antigen. |
| Q36018172 | Dysfunction of natural killer T cells in patients with active Mycobacterium tuberculosis infection |
| Q37187603 | Glycolipid ligands of invariant natural killer T cells as vaccine adjuvants |
| Q36487871 | HIV Disrupts Human T Cells That Target Mycobacterial Glycolipids |
| Q36815449 | HIV-1 and the immune response to TB. |
| Q37152701 | Hallmarks of Tissue-Resident Lymphocytes |
| Q37349692 | Harnessing invariant NKT cells in vaccination strategies |
| Q37286356 | Incorporation of NKT cell-activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette-Guerin |
| Q90559897 | Innate T cells in the intensive care unit |
| Q35213598 | Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection |
| Q33392693 | Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria |
| Q37822744 | Invariant NK T cells: potential for immunotherapeutic targeting with glycolipid antigens |
| Q42789726 | Invariant NKT cell anergy is induced by a strong TCR-mediated signal plus co-stimulation |
| Q36739848 | Invariant natural killer T cells: bridging innate and adaptive immunity |
| Q37458940 | Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities |
| Q42717336 | Key role for respiratory CD103(+) dendritic cells, IFN-γ, and IL-17 in protection against Streptococcus pneumoniae infection in response to α-galactosylceramide |
| Q37104082 | MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection |
| Q34595935 | Mycobacterium tuberculosis strains lacking surface lipid phthiocerol dimycocerosate are susceptible to killing by an early innate host response |
| Q57171137 | Natural Killer T Cells and Mucosal-Associated Invariant T Cells in Lung Infections |
| Q30488777 | PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells |
| Q34860648 | Parenchymal expression of CD40 exacerbates adenovirus-induced hepatitis in mice. |
| Q39753175 | Rapid and reliable generation of invariant natural killer T-cell lines in vitro |
| Q26801636 | Role of Group 1 CD1-Restricted T Cells in Infectious Disease |
| Q27026700 | Role of non-conventional T lymphocytes in respiratory infections: the case of the pneumococcus |
| Q38150638 | Role of type 1 natural killer T cells in pulmonary immunity |
| Q40556221 | Selective Conditions Are Required for the Induction of Invariant NKT Cell Hyporesponsiveness by Antigenic Stimulation |
| Q27003411 | Stages versus subsets: Invariant Natural Killer T cell lineage differentiation |
| Q34305284 | The ROS scavenger, NAC, regulates hepatic Vα14iNKT cells signaling during Fas mAb-dependent fulminant liver failure |
| Q35600087 | The Response of CD1d-Restricted Invariant NKT Cells to Microbial Pathogens and Their Products |
| Q91526061 | The protein tyrosine kinase SYK regulates the alternative p38 activation in liver during acute liver inflammation |
| Q37122052 | The role of hepatic invariant NKT cells in systemic/local inflammation and mortality during polymicrobial septic shock |
| Q30432794 | Toll-like receptor 3 ligand dampens liver inflammation by stimulating Valpha 14 invariant natural killer T cells to negatively regulate gammadeltaT cells |
| Q30433085 | V(alpha)14iNKT cells promote liver pathology during adenovirus infection by inducing CCL5 production: implications for gene therapy |
| Q37846863 | Views of immunology: effector T cells |